Brief: Agile Therapeutics Granted 180-Day Extension By Nasdaq To Meet The Minimum Bid Price Requirement
27/02/2023 13:45
Feb 27 (Reuters) - Agile Therapeutics Inc AGRX.O :
* AGILE THERAPEUTICS GRANTED 180-DAY EXTENSION BY NASDAQ TO
MEET
THE MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: ID:nGNX3kzkmJ
Further company coverage: AGRX.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Agile Therapeutics
See all newsBrief: Agile Therapeutics Inc. Announces Definitive Merger Agreement With Insud Pharma, S.L.
Agile Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Agile Therapeutics Announces Delisting From Nasdaq
Agile Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Agile Therapeutics Completes Pay-Off Of Debt